oktober 18, 2017
Funds further company’s mission to identify and de-risk preclinical rare disease therapeutics, ultimately, spinning out companies with IND-ready programs – Cydan expands leadership team with new chief medical officer and vice president of development Cambridge, Mass., October 17, 2017 – Cydan today announced a new round of financing, raising a committed total of $34 million to advance the company’s...


90 mio. kr. til 18 talentfulde forskere
19. oktober 2020
Søren Dinesen Lumdbeckfonden
Psykiatriforskning udløser stor videnskabelig pris
13. oktober 2020
Christian Sandøe Musaeus Lundbeckfonden
Han satser på demensområdet
13. oktober 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge